ID: ALA5277579

Max Phase: Preclinical

Molecular Formula: C8H10N4O

Molecular Weight: 178.19

Associated Items:

Representations

Canonical SMILES:  CCCc1cc(=O)n2ncnc2[nH]1

Standard InChI:  InChI=1S/C8H10N4O/c1-2-3-6-4-7(13)12-8(11-6)9-5-10-12/h4-5H,2-3H2,1H3,(H,9,10,11)

Standard InChI Key:  KZPRAIXAZRGXPX-UHFFFAOYSA-N

Associated Targets(Human)

C-type lectin domain family 4 member M 115 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 178.19Molecular Weight (Monoisotopic): 178.0855AlogP: 0.37#Rotatable Bonds: 2
Polar Surface Area: 63.05Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.48CX Basic pKa: CX LogP: 1.18CX LogD: 1.18
Aromatic Rings: 2Heavy Atoms: 13QED Weighted: 0.72Np Likeness Score: -1.49

References

1. Sethi A, Sanam S, Alvala M..  (2021)  Non-carbohydrate strategies to inhibit lectin proteins with special emphasis on galectins.,  222  [PMID:34146913] [10.1016/j.ejmech.2021.113561]

Source